These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20159247)

  • 21. Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children.
    Raissy HH; Harkins M; Kelly F; Kelly HW
    Pharmacotherapy; 2008 Mar; 28(3):287-94. PubMed ID: 18294107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind, randomised, controlled trial assessing controller medications in asthma.
    Shah AR; Sharples LD; Solanki RN; Shah KV
    Respiration; 2006; 73(4):449-56. PubMed ID: 16407639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.
    Philip G; van Adelsberg J; Loeys T; Liu N; Wong P; Lai E; Dass SB; Reiss TF
    J Allergy Clin Immunol; 2009 Nov; 124(5):942-8.e1-9. PubMed ID: 19748656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium cromoglycate alone and in combination with montelukast on the airway response to mannitol in asthmatic subjects.
    Anderson SD; Brannan JD; Perry CP; Caillaud C; Seale JP
    J Asthma; 2010 May; 47(4):429-33. PubMed ID: 20528598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma.
    van Adelsberg J; Moy J; Wei LX; Tozzi CA; Knorr B; Reiss TF
    Curr Med Res Opin; 2005 Jun; 21(6):971-9. PubMed ID: 15969897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.
    Busse W; Raphael GD; Galant S; Kalberg C; Goode-Sellers S; Srebro S; Edwards L; Rickard K;
    J Allergy Clin Immunol; 2001 Mar; 107(3):461-8. PubMed ID: 11240946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
    Jayaram L; Pizzichini E; Lemière C; Man SF; Cartier A; Hargreave FE; Pizzichini MM
    Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy and tolerability of inhaled montelukast plus inhaled mometasone compared with mometasone alone in patients with chronic asthma.
    Philip G; Villarán C; Shah SR; Vandormael K; Smugar SS; Reiss TF
    J Asthma; 2011 Jun; 48(5):495-502. PubMed ID: 21545249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.
    Lu S; Malice MP; Dass SB; Reiss TF
    J Asthma; 2009 Nov; 46(9):878-83. PubMed ID: 19905912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of 3-5 months' add-on therapy with montelukast in patients with non-controlled asthma in Austria: the STAR open-label, real-world, observational study.
    Schlick W; Pohl W; Pfeiffer KP; Aigner K; Forche G; Kneussl M; Zwick H
    Curr Med Res Opin; 2010 Mar; 26(3):561-70. PubMed ID: 20050815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline predictors of placebo response in exercise-induced bronchoconstriction (EIB): pooled regression analysis >from three studies of montelukast in EIB.
    Philip G; Swern AS; Smugar SS; Pearlman DS
    J Asthma; 2010 Oct; 47(8):935-41. PubMed ID: 20858150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of montelukast for treatment of asthma in cigarette smokers.
    Price D; Popov TA; Bjermer L; Lu S; Petrovic R; Vandormael K; Mehta A; Strus JD; Polos PG; Philip G
    J Allergy Clin Immunol; 2013 Mar; 131(3):763-71. PubMed ID: 23380218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukast.
    Philip G; Villarán C; Pearlman DS; Loeys T; Dass SB; Reiss TF
    J Asthma; 2007 Apr; 44(3):213-7. PubMed ID: 17454341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthma.
    Philip G; Pedinoff A; Vandormael K; Tymofyeyev Y; Smugar SS; Reiss TF; Korenblat PE
    J Asthma; 2010 Dec; 47(10):1078-84. PubMed ID: 20936994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can montelukast shorten prednisolone therapy in children with mild to moderate acute asthma? A randomized controlled trial.
    Schuh S; Willan AR; Stephens D; Dick PT; Coates A
    J Pediatr; 2009 Dec; 155(6):795-800. PubMed ID: 19656525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
    Zeiger RS; Bird SR; Kaplan MS; Schatz M; Pearlman DS; Orav EJ; Hustad CM; Edelman JM
    Am J Med; 2005 Jun; 118(6):649-57. PubMed ID: 15922697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Onset and duration of attenuation of exercise-induced bronchoconstriction in children by single-dose of montelukast.
    Wasfi YS; Kemp JP; Villarán C; Massaad R; Xin W; Smugar SS; Knorr BA; Philip G
    Allergy Asthma Proc; 2011; 32(6):453-9. PubMed ID: 22221440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of behavior-related adverse experiences in clinical trials of montelukast.
    Philip G; Hustad CM; Malice MP; Noonan G; Ezekowitz A; Reiss TF; Knorr B
    J Allergy Clin Immunol; 2009 Oct; 124(4):699-706.e8. PubMed ID: 19815116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure.
    Perry TT; Corren J; Philip G; Kim EH; Conover-Walker MK; Malice MP; Massaad R; Dass SB; Reiss TF; Wood RA
    Ann Allergy Asthma Immunol; 2004 Nov; 93(5):431-8. PubMed ID: 15562881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.